Market Overview

Acacia Subsidiary Enters into Settlement Agreement with AstraZeneca

Related ACTG
Acacia Research Owns More In Veritone Than Its Own Market Cap
20 Biggest Mid-Day Losers For Wednesday

Acacia Research Corporation (NASDAQ: ACTG) announced today that its
Accuhale LLC subsidiary has entered into a settlement agreement
regarding pressurized metered dose inhalers with AstraZeneca LP (NYSE: AZN),
AstraZeneca Pharmaceuticals LP, AstraZeneca Dunkerque Production SCS and
AstraZeneca AB. The agreement resolves litigation that was pending in
the United States District Court for the Eastern District of Texas.

See full press release

Posted-In: News Guidance Contracts Asset Sales Legal Management Global


Related Articles (ACTG + AZN)

View Comments and Join the Discussion!